Solute carrier family 12 member 3 and solute carrier family 12 member 1 (NCC/NKCC2)

This entry refers to two distinct members of the solute carrier family 12 (SLC12) that are essential for renal electrolyte handling: the Na+/Cl− cotransporter (NCC, encoded by SLC12A3) and the Na+/K+/2Cl− cotransporter 2 (NKCC2, encoded by SLC12A1) (UniProt P55017, Q13621). NCC is primarily expressed in the distal convoluted tubule and is the molecular target of thiazide diuretics, while NKCC2 is located in the thick ascending limb of the loop of Henle and is targeted by loop diuretics (StatPearls, 2023). Both transporters mediate the reabsorption of sodium and chloride from the tubular fluid, playing a critical role in maintaining blood pressure and extracellular fluid volume (PubMed, 2011). Mutations in these transporters lead to salt-losing tubulopathies, specifically Gitelman syndrome (NCC) and Bartter syndrome (NKCC2) (NIH, 2021). Pharmacological inhibition of these cotransporters is a standard therapeutic approach for managing hypertension, edema, and congestive heart failure (PubMed, 2014).

Other names

SLC12A3SLC12A1Thiazide-sensitive Na-Cl cotransporterBumetanide-sensitive Na-K-2Cl cotransporterNCCNKCC2BSC1TSC

Inhibition of ion reabsorption in the renal tubules (distal convoluted tubule for NCC and thick ascending limb for NKCC2), leading to increased urinary excretion of sodium, chloride, and water (diuresis).